Biomarkers of cardiovascular disease risk in the neonatal population
暂无分享,去创建一个
H. Milionis | Maria S Baltogianni | D. Rallis | V. Giapros | Antonios P. Vlahos | Alexandra Lianou | Dimitrios Rallis
[1] J. Vendrell,et al. Cord Blood Advanced Lipoprotein Testing Reveals an Interaction between Gestational Diabetes and Birth-Weight and Suggests a New Early Biomarker of Infant Obesity , 2022, Biomedicines.
[2] Jieying Liu,et al. Metabolomics Applied to Cord Serum in Preeclampsia Newborns: Implications for Neonatal Outcomes , 2022, Frontiers in Pediatrics.
[3] Huiying Liang,et al. Insulin resistance biomarkers in small-for-gestational-age infants born to mothers with gestational diabetes mellitus , 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[4] M. Cantinotti,et al. High-sensitivity cardiac troponins in pediatric population , 2021, Clinical chemistry and laboratory medicine.
[5] A. Gu,et al. Association between birth weight and risk of cardiovascular disease: Evidence from UK Biobank. , 2021, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[6] D. Rallis,et al. C-reactive protein in infants with no evidence of early-onset sepsis , 2021, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[7] Sujoy Ghosh,et al. Lipid Profile in Infant , 2021, Indian journal of endocrinology and metabolism.
[8] K. Safranow,et al. Differential Secretion of Angiopoietic Factors and Expression of MicroRNA in Umbilical Cord Blood from Healthy Appropriate-For-Gestational-Age Preterm and Term Newborns—in Search of Biomarkers of Angiogenesis-Related Processes in Preterm Birth , 2020, International journal of molecular sciences.
[9] J. Shaw,et al. Cord blood metabolic markers are strong mediators of the effect of maternal adiposity on fetal growth in pregnancies across the glucose tolerance spectrum: the PANDORA study , 2020, Diabetologia.
[10] M. F. Fuentes Ferrer,et al. Early markers of endocrinometabolic disease in newborns with delayed intrauterine growth. , 2019, Clinical nutrition ESPEN.
[11] G. Dimitriou,et al. Osteoprotegerin and RANKL serum concentrations in neonates of mothers with early-onset pre-eclampsia: comparison with neonates of normotensive mothers. , 2019, Early human development.
[12] S. Blankenberg,et al. Cardiovascular Biomarkers in Amniotic Fluid, Umbilical Arterial Blood, Umbilical Venous Blood, and Maternal Blood at Delivery, and Their Reference Values for Full-Term, Singleton, Cesarean Deliveries , 2019, Front. Pediatr..
[13] Didem Arman,et al. The relationship between serum vitamin D levels and intima-media thickness in term infants , 2019, European Journal of Pediatrics.
[14] D. Glueck,et al. Cord Blood Vitamin D Levels and Early Childhood Blood Pressure: The Healthy Start Study , 2019, Journal of the American Heart Association.
[15] W. Fraser,et al. Placental 11β-HSD2 and Cardiometabolic Health Indicators in Infancy , 2019, Diabetes Care.
[16] C. Mantzoros,et al. Leptin trajectories from birth to mid-childhood and cardio-metabolic health in early adolescence. , 2019, Metabolism: clinical and experimental.
[17] M. Rudge,et al. BCL2 and miR-181a transcriptional alterations in umbilical-cord blood cells can be putative biomarkers for obesity. , 2018, Mutation research. Genetic toxicology and environmental mutagenesis.
[18] E. Grywalska,et al. Selected risk factors for atherosclerosis in children and their parents with positive family history of premature cardiovascular diseases: a prospective study , 2018, BMC Pediatrics.
[19] A. Malamitsi‐Puchner,et al. Potential prognostic biomarkers of cardiovascular disease in fetal macrosomia: the impact of gestational diabetes , 2018, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[20] F. Bloomfield,et al. Consensus Based Definition of Growth Restriction in the Newborn , 2018, The Journal of pediatrics.
[21] E. Gratacós,et al. Cord Blood Biomarkers of Cardiac Dysfunction and Damage in Term Growth-Restricted Fetuses Classified by Severity Criteria , 2017, Fetal Diagnosis and Therapy.
[22] Kyung-Hyun Cho,et al. Cord and maternal sera from small neonates share dysfunctional lipoproteins with proatherogenic properties: Evidence for Barker's hypothesis. , 2017, Journal of clinical lipidology.
[23] R. Vitorino,et al. Prediction of cardiovascular risk in preterm neonates through urinary proteomics: An exploratory study , 2017, Porto biomedical journal.
[24] K. Gandhi. Approach to hypoglycemia in infants and children. , 2017, Translational pediatrics.
[25] K. Adeli,et al. The Canadian laboratory initiative on pediatric reference intervals: A CALIPER white paper , 2017, Critical reviews in clinical laboratory sciences.
[26] A. Cahill,et al. Markers of Maternal and Infant Metabolism are Associated with Ventricular Dysfunction in Infants of Obese Women with Type 2 Diabetes , 2017, Pediatric Research.
[27] J. Gouyon,et al. Low Plasma Protein Levels at Birth Are Associated with Poor Cardiovascular Adaptation and Serious Adverse Outcome in Infants with Gestational Age <32 Weeks: The ProHémie Study , 2017, Neonatology.
[28] K. Thornburg,et al. Neonatal fatty acid profiles are correlated with infant growth measures at 6 months , 2017, Journal of Developmental Origins of Health and Disease.
[29] L. Dodds,et al. Birth Weight for Gestational Age, Anthropometric Measures, and Cardiovascular Disease Markers in Children , 2017, The Journal of pediatrics.
[30] R. Kishi,et al. Prenatal di-2-ethylhexyl phthalate exposure and cord blood adipokine levels and birth size: The Hokkaido study on environment and children's health. , 2017, The Science of the total environment.
[31] A. Farrokh,et al. Fetal gender and gestational age differentially affect PCSK9 levels in intrauterine growth restriction , 2016, Lipids in Health and Disease.
[32] B. Mol,et al. Preeclampsia; short and long-term consequences for mother and neonate. , 2016, Early human development.
[33] T. Çelik,et al. Adipokine, adropin and endothelin-1 levels in intrauterine growth restricted neonates and their mothers , 2016, Journal of perinatal medicine.
[34] J. Després,et al. Utility of the hypertriglyceridemic waist phenotype in the cardiometabolic risk assessment of youth stratified by body mass index , 2016, Pediatric obesity.
[35] M. Cheung,et al. Inflammation, lipids and aortic intima‐media thickness in newborns following chorioamnionitis , 2016, Acta paediatrica.
[36] R. Huo,et al. Peptidome profiling of umbilical cord plasma associated with gestational diabetes-induced fetal macrosomia. , 2016, Journal of proteomics.
[37] S. Blankenberg,et al. Cardiovascular biomarkers in paired maternal and umbilical cord blood samples at term and near term delivery. , 2016, Early human development.
[38] D. Corella,et al. Maternal and neonatal FTO rs9939609 polymorphism affect insulin sensitivity markers and lipoprotein profile at birth in appropriate-for-gestational-age term neonates , 2016, Journal of Physiology and Biochemistry.
[39] Hongying Wang,et al. Evaluation of the regional ventricular systolic function by two-dimensional strain echocardiography in gestational diabetes mellitus (GDM) fetuses with good glycemic control , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[40] L. Pacifico,et al. Fetal and early neonatal interleukin-6 response. , 2015, Cytokine.
[41] S. Topçuoğlu,et al. The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers. , 2015, Diabetes research and clinical practice.
[42] N. Abril,et al. Alterations of protein expression in serum of infants with intrauterine growth restriction and different gestational ages. , 2015, Journal of proteomics.
[43] R. Brohet,et al. Reference Values for Interleukin-6 and Interleukin-8 in Cord Blood of Healthy Term Neonates and Their Association with Stress-Related Perinatal Factors , 2014, PloS one.
[44] E. Petrucci,et al. Serum Reference Values for Leptin in Healthy Infants , 2014, PloS one.
[45] H. Scharnagl,et al. Gestational diabetes mellitus modulates neonatal high-density lipoprotein composition and its functional heterogeneity. , 2014, Biochimica et biophysica acta.
[46] K. Kusuhara,et al. Circulating PCSK9 levels correlate with the serum LDL cholesterol level in newborn infants. , 2014, Early human development.
[47] J. Vendrell,et al. Gender determines the actions of adiponectin multimers on fetal growth and adiposity. , 2013, American journal of obstetrics and gynecology.
[48] S. Yıldırım,et al. Adiponectin and visfatin levels in extremely low birth weight infants; they are also at risk for insulin resistance. , 2013, European review for medical and pharmacological sciences.
[49] E. Bairaktari,et al. Vitamin D Levels and Insulin Resistance in Children Born with Severe Growth Restriction , 2012, Hormone and Metabolic Research.
[50] A. Korraa,et al. Cardiac troponin I levels and its relation to echocardiographic findings in infants of diabetic mothers , 2012, Italian Journal of Pediatrics.
[51] M. Rodríguez-Moran,et al. Birth-weight, insulin levels, and HOMA-IR in newborns at term , 2012, BMC Pediatrics.
[52] C. D. de Groot,et al. E-selectin is elevated in cord blood of South Asian neonates compared with Caucasian neonates. , 2012, The Journal of pediatrics.
[53] S. Daniels. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents: Summary Report , 2011, Pediatrics.
[54] S. Daniels,et al. Nontraditional Risk Factors and Biomarkers for Cardiovascular Disease: Mechanistic, Research, and Clinical Considerations for Youth A Scientific Statement From the American Heart Association , 2011, Circulation.
[55] E. Levy,et al. Oxidized low-density lipoproteins in cord blood from neonates with intra-uterine growth restriction. , 2011, European journal of obstetrics, gynecology, and reproductive biology.
[56] M. Zugaib,et al. Cardiac troponin T as a biochemical marker of cardiac dysfunction and ductus venosus Doppler velocimetry. , 2009, European journal of obstetrics, gynecology, and reproductive biology.
[57] E. Ford,et al. Trends in the Prevalence of Low Risk Factor Burden for Cardiovascular Disease Among United States Adults , 2009, Circulation.
[58] F. Verlato,et al. Arterial wall thickness and blood pressure in children who were born small for gestational age: correlation with umbilical cord high-sensitivity C-reactive protein , 2009, Archives of Disease in Childhood.
[59] Elisenda Eixarch,et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. , 2008, American journal of obstetrics and gynecology.
[60] W. Hop,et al. Left ventricular isovolumic relaxation and renin-angiotensin system in the growth restricted fetus. , 2008, European journal of obstetrics, gynecology, and reproductive biology.
[61] P. Davis,et al. Cardiac troponin T and N-terminal-pro-B type natriuretic peptide reflect myocardial function in preterm infants , 2008, Journal of Perinatology.
[62] D. Kiortsis,et al. Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight. , 2007, Clinical endocrinology.
[63] N. Iacovidou,et al. Perinatal Changes of Circulating N-Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) in Normal and Intrauterine-Growth-Restricted Pregnancies , 2007, Hypertension in pregnancy.
[64] M. Plebani,et al. High-Sensitivity C-Reactive Protein in Umbilical Cord of Small-for-Gestational-Age Neonates , 2006, Neonatology.
[65] J. Bornstein,et al. Newborns of pre‐eclamptic women: a biochemical difference present in utero , 2006, Acta obstetricia et gynecologica Scandinavica.
[66] B. Geloneze,et al. Atherogenic lipid profile of Brazilian near-term newborns. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.
[67] E. Garrett,et al. A large high-density lipoprotein enriched in apolipoprotein C-I: a novel biochemical marker in infants of lower birth weight and younger gestational age. , 2005, JAMA.
[68] D. Barker,et al. The Developmental Origins of Adult Disease , 2004, Journal of the American College of Nutrition.
[69] H. Baum,et al. Reference values for cardiac troponins T and I in healthy neonates. , 2004, Clinical biochemistry.
[70] I. Yokota,et al. Plasma adiponectin levels in newborns are higher than those in adults and positively correlated with birth weight , 2004, Clinical endocrinology.
[71] P. Ueland,et al. Screening for serum total homocysteine in newborn children. , 2004, Clinical chemistry.
[72] T. Rönnemaa,et al. Impaired left ventricular diastolic function in newborn infants of mothers with pregestational or gestational diabetes with good glycemic control. , 2004, Early human development.
[73] E. Sivan,et al. Adiponectin in human cord blood: relation to fetal birth weight and gender. , 2003, The Journal of clinical endocrinology and metabolism.
[74] S. Andersson,et al. Vascular Endothelial Growth Factor and Angiogenin Levels during Fetal Development and in Maternal Diabetes , 2003, Neonatology.
[75] T. Carrel,et al. Age-Specific Analysis of Normal Cytokine Levels in Healthy Infants , 2003, Clinical chemistry and laboratory medicine.
[76] J. Bonnar,et al. The effect of pre-eclampsia on coagulation and fibrinolytic activation in the neonate. , 2000, Thrombosis research.
[77] M. Panteghini,et al. Cardiac troponin T in serum as marker for myocardial injury in newborns. , 1997, Clinical chemistry.
[78] E. Gratacós,et al. Fetal cardiac remodeling and dysfunction is associated with both preeclampsia and fetal growth restriction. , 2019, American Journal of Obstetrics and Gynecology.
[79] L. Poston,et al. Cord Metabolic Profiles in Obese Pregnant Women: Insights Into Offspring Growth and Body Composition , 2018, The Journal of clinical endocrinology and metabolism.
[80] M. Cruz López,et al. [Placental atherosclerosis and markers of endothelial dysfunction in infants born to mothers with gestational diabetes]. , 2016, Medicina clinica.
[81] A. Yaman,et al. Troponin T and NT ProBNP Levels in Gestational, Type 1 and Type 2 Diabetic Mothers and Macrosomic Infants , 2015, Pediatric Cardiology.
[82] S. Bastida,et al. Relationships between serum calcium and magnesium levels and lipoproteins, homocysteine and insulin resistance/sensitivity markers at birth. , 2014, Nutricion hospitalaria.
[83] B. Gersh. Trends in the Prevalence of Low Risk Factor Burden for Cardiovascular Disease Among United States Adults , 2010 .
[84] T. Murakami,et al. Dynamic Changes in Serum Leptin Concentrations during the Fetal and Neonatal Periods , 1999, Pediatric Research.
[85] ScienceDirect. Nutrition, metabolism, and cardiovascular diseases : NMCD. , 1991 .